ScholarIQanswers from OpenAlex

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease

PaperCitations, authors & open-access status

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease have?

ScholarIQcitation count

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease has 25 citations in the OpenAlex counts ScholarIQ stores.

When was Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease published?

ScholarIQyear

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease has 2017 year in the ScholarIQ index.

What is the open-access status of Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease?

ScholarIQoa status

Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease has closed oa status in the ScholarIQ index.

What is the DOI of Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease?

ScholarIQdoi

The DOI for Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease is on the source record.

What is the PMID of Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease?

ScholarIQpmid

The PMID for Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease is on the source record.

What is the OpenAlex record for Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease?

ScholarIQopenalex

The OpenAlex for Urinary 11-Dehydro-Thromboxane B 2 and Mortality in Patients With Stable Coronary Artery Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial